• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7

CATEGORIES

  • 11
  • 10
  • 7
  • 4
  • 1
  • 1
  • 1
  • 1

PRICE

9
9
29
35

PUBLISHED

3
7
16
35

PRODUCT TYPE

24
11

Search "Impax Laboratories Inc.-Detailed Product Pipeline" returned 35 results.

Impax Laboratories, Inc. - Product Pipeline Review - 2014

Impax Laboratories, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Impax Laboratories, Inc. - Product Pipeline Review - 2014’, provides an overview of the Impax Laboratories,...

February 2014
FROM

IMPAX Laboratories, Inc. - Product Pipeline Review - 2012

IMPAX Laboratories, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “IMPAX Laboratories, Inc. - Product Pipeline Review - 2012” provides data on the IMPAX...

August 2012
FROM

IMPAX Laboratories, Inc. - Product Pipeline Review - H2 2011

IMPAX Laboratories, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “IMPAX Laboratories, Inc. - Product Pipeline Review - H2 2011” provides data on...

November 2011
FROM

IMPAX Laboratories, Inc. - Product Pipeline Review - Q1 2011

IMPAX Laboratories, Inc. – Product Pipeline Review – Q1 2011 Summary Global Market Direct’s pharmaceuticals report, “IMPAX Laboratories, Inc. - Product Pipeline Review - Q1 2011” provides data on...

May 2011
FROM

IMPAX Laboratories, Inc. - Product Pipeline Review - Q4 2010

IMPAX Laboratories, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “IMPAX Laboratories, Inc. - Product Pipeline Review - Q4 2010” provides data on...

December 2010
FROM

Global Migraine Drugs Market 2015-2019

About Migraine Migraine is a complex neurological medicial condition characterized by a severe headache. The headache is often accompanied by nausea, vomiting, and extreme sensitivity to light and sound....

February 2015
FROM

Migraine - Pipeline Review, H1 2014

Migraine - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2014’, provides an overview of the Migraine’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM

Postherpetic Neuralgia - Pipeline Review, H1 2014

Postherpetic Neuralgia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H1 2014’, provides an overview of the Postherpetic Neuralgia’s therapeutic...

March 2014
FROM

Migraine - Pipeline Review, H2 2014

Migraine - Pipeline Review, H2 2014 Summary This, ‘Migraine - Pipeline Review, H2 2014’, provides an overview of the Migraine’s therapeutic pipeline. This report provides comprehensive information...

July 2014
FROM

Epilepsy - Pipeline Review, H1 2014

Epilepsy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H1 2014’, provides an overview of the Epilepsy’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM

Parkinson's Disease - Pipeline Review, H1 2014

Parkinson's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2014’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This...

February 2014
FROM

Chronic Back Pain - Pipeline Review, H2 2014

Chronic Back Pain - Pipeline Review, H2 2014 Summary This, ‘Chronic Back Pain - Pipeline Review, H2 2014’, provides an overview of the Chronic Back Pain’s therapeutic pipeline. This report provides...

August 2014
FROM

Postherpetic Neuralgia - Pipeline Review, H2 2014

Postherpetic Neuralgia - Pipeline Review, H2 2014 Summary This, ‘Postherpetic Neuralgia - Pipeline Review, H2 2014’, provides an overview of the Postherpetic Neuralgia’s therapeutic pipeline. This...

August 2014
FROM

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2014

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2014’, provides an...

March 2014
FROM

Anxiety Disorders- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Anxiety Disorders- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

August 2015
FROM

Low Back Pain - Pipeline Review, H1 2014

Low Back Pain - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Low Back Pain - Pipeline Review, H1 2014’, provides an overview of the Low Back Pain’s therapeutic pipeline. This report...

May 2014
FROM

Schizophrenia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Schizophrenia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

August 2015
FROM

Migraine- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Migraine- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

August 2015
FROM

Depression - Pipeline Review, H1 2014

Depression - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2014’, provides an overview of the Depression’s therapeutic pipeline. This report provides...

April 2014
FROM

Overactive Bladder - Pipeline Review, H1 2014

Overactive Bladder - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Overactive Bladder - Pipeline Review, H1 2014’, provides an overview of the Overactive Bladder’s therapeutic pipeline. This...

March 2014
FROM
Loading Indicator

Our Clients

Procter & Gamble Co. Western Union Company Volvo Car Corporation Morgan Stanley SAP SE LG Corporation Roche Diagnostics Ltd.